Summit X LLC’s Boston Scientific BSX Stock Holding History

Summit X LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,353	Closed	-$306	–	273
2020 Q3	$306	Buy	+1,353	New	+$52.1K	0.01%	363

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Summit X LLC's BSX Position: Q4 2020 in Review

Summit X LLC sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 1,353 shares — an estimated $306 sold.

Summit X LLC first reported a position in BSX in Q3 2020 and held it in 1 quarter. The position peaked at $306 in Q3 2020. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

Summit X LLC reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
Summit X LLC sold 1,353 Boston Scientific shares in Q4 2020, an estimated $306.
Summit X LLC first reported a position in Boston Scientific in Q3 2020 and held it in 1 quarter.
Summit X LLC's Boston Scientific position peaked at $306 in Q3 2020.
863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Summit X LLC's 13F filing for Q4 2020, filed 29 Jan 2021.